FDA teams up with Optivia Biotechnology to assess supplement-drug interactions
The U.S. Food and Drug Administration (FDA) and San Francisco-based Optivia Biotechnology have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.